Reshaping genomic research for innovative therapies
No one part of the body works alone, including our DNA. Our genomes directly and indirectly influence all aspects of our health, connecting the cells in our bodies with a common genetic code. That's why our researchers and healthcare providers are connecting across the globe with a common goal - to study the interconnected ways our genomes determine human health and disease.
Learn about our global mission
Research News
Systems biology and AI genetic analyses identify potential genetic factors influencing Parkinson’s disease and repurposable drugs for Parkinson's disease treatment.
The artificial intelligence algorithm identified multiple gut metabolites and FDA-approved drugs that have potential to be repurposed as non-addictive, non-opioid pain medications.
The Cleveland Clinic study provides evidence needed to justify new clinical trials for repurposing FDA-approved hypertension, erectile dysfunction drug to also treat Alzheimer’s disease.